Brief: Ortho Regenerative Technologies Announces Filing Of Response To Type A Meeting With FDA And Non-Brokered $1.5 Mln Private Placement
12/11/2021 12:23
Nov 12 (Reuters) - Ortho Regenerative Technologies Inc
ORTH.CD :
* ORTHO REGENERATIVE TECHNOLOGIES ANNOUNCES FILING OF
RESPONSE TO
TYPE A MEETING WITH FDA AND NON-BROKERED $1.5 MILLION PRIVATE
PLACEMENT
* ORTHO REGENERATIVE TECHNOLOGIES INC - INSIDERS TO LEAD
PRIVATE
PLACEMENT WITH SUBSCRIPTIONS TOTALING MORE THAN $400,000
Source text for Eikon: ID:nCNWb3wlVa
Further company coverage: ORTH.CD
((Reuters.Briefs@thomsonreuters.com;;))
Recent news on Chitogenx
See all newsBrief: Chitogenx Announces Signing Of Binding Letter Of Intent With Oligo Medic
Brief: Chitogenx Announces Executive Leadership Changes
Brief: Chitogenx Inc - Study Results To Be Available Q3-24 After Mandatory Post-Surgery Monitoring
Brief: Chitogenx Concludes Enrolment For Its U.S. Phase I/II Rotator Cuff Tear Repair Clinical Trial
Brief: Chitogenx Announces New $2.5 Million Non-Brokered Private Placement Offering And Balance Sheet Restructuring